|
1
|
Balany J and Bhandari V: Understanding the
impact of infection, inflammation, and their persistence in the
pathogenesis of bronchopulmonary dysplasia. Front Med (Lausanne).
2:902015.PubMed/NCBI
|
|
2
|
Bhandari V: Hyperoxia-derived lung damage
in preterm infants. Semin Fetal Neonatal Med. 15:223–229. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fernandez-Gonzalez A, Alex Mitsialis S,
Liu X and Kourembanas S: Vasculoprotective effects of heme
oxygenase-1 in a murine model of hyperoxia-induced bronchopulmonary
dysplasia. Am J Physiol Lung Cell Mol Physiol. 302:L775–L784. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Muramatsu Y, Ito M, Oshima T, Kojima S and
Ohno K: Hydrogen-rich water ameliorates bronchopulmonary dysplasia
(BPD) in newborn rats. Pediatr Pulmonol. 51:928–935. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kumar VH, Lakshminrusimha S, Kishkurno S,
Paturi BS, Gugino SF, Nielsen L, Wang H and Ryan RM: Neonatal
hyperoxia increases airway reactivity and inflammation in adult
mice. Pediatr Pulmonol. 51:1131–1141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schreiner C, Schreiner F, Härtel C,
Heckmann M, Heep A, Bartmann P, Woelfle J, Müller A, Herting E and
Göpel W; German Neonatal Network GNN, : Glucocorticoid receptor
gene variants and neonatal outcome in very-low-birth-weight preterm
infants. Neonatol. 111:22–29. 2016. View Article : Google Scholar
|
|
7
|
Lakshminrusimha S, Mathew B and Leach CL:
Pharmacologic strategies in neonatal pulmonary hypertension other
than nitric oxide. Semin Perinatol. 40:160–173. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Slaughter JL, Stenger MR, Reagan PB and
Jadcherla SR: Utilization of inhaled corticosteroids for infants
with bronchopulmonary dysplasia. PLoS One. 9:e1068382014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Serhan CN, Chiang N and Van Dyke TE:
Resolving inflammation: Dual anti-inflammatory and pro-resolution
lipid mediators. Nat Rev Immunol. 8:349–361. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fiorucci S, Wallace JL, Mencarelli A,
Distrutti E, Rizzo G, Farneti S, Morelli A, Tseng JL, Suramanyam B,
Guilford WJ and Parkinson JF: A beta-oxidation-resistant lipoxin
A4 analog treats hapten-induced colitis by attenuating
inflammation and immune dysfunction. Proc Natl Acad Sci USA.
101:15736–15741. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ye XH, Wu Y, Guo PP, Wang J, Yuan SY,
Shang Y and Yao SL: Lipoxin A4 analogue protects brain
and reduces inflammation in a rat model of focal cerebral ischemia
reperfusion. Brain Res. 1323:174–183. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Levy BD, De Sanctis GT, Devchand PR, Kim
E, Ackerman K, Schmidt BA, Szczeklik W, Drazen JM and Serhan CN:
Multi-pronged inhibition of airway hyper-responsiveness and
inflammation by lipoxin A(4). Nat Med. 8:1018–1023. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang F, Xie J, Wang W, Xie Y, Sun H, Jin
Y, Xu D, Chen B, Andersson R and Zhou M: Regional arterial infusion
with lipoxin A4 attenuates experimental severe acute
pancreatitis. PLoS One. 9:e1085252014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang M, Chen L, Li B, Wang Y, Li S, Wen A,
Yao S and Shang Y: BML-111 attenuates acute lung injury in
endotoxemic mice. J Surg Res. 200:619–630. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu SH, Liao PY, Dong L and Chen ZQ: Signal
pathway involved in inhibition by lipoxin A(4) of production of
interleukins induced in endothelial cells by lipopolysaccharide.
Inflamm Res. 57:430–437. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hangaishi M, Ishizaka N, Aizawa T,
Kurihara Y, Taguchi J, Nagai R, Kimura S and Ohno M: Induction of
heme oxygenase-1 can act protectively against cardiac
ischemia/reperfusion in vivo. Biochem Biophys Res Commun.
279:582–588. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen XQ, Wu SH, Zhou Y and Tang YR:
Lipoxin A4-induced heme oxygenase-1 protects
cardiomyocytes against hypoxia/reoxygenation injury via p38 MAPK
activation and Nrf2/ARE complex. PLoS One. 8:e671202013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Biteman B, Hassan IR, Walker E, Leedom AJ,
Dunn M, Seta F, Laniado-Schwartzman M and Gronert K:
Interdependence of lipoxin A4 and heme-oxygenase in
counter-regulating inflammation during corneal wound healing. FASEB
J. 21:2257–2266. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Martin CR, Zaman MM, Gilkey C, Salguero
MV, Hasturk H, Kantarci A, Van Dyke TE and Freedman SD: Resolvin D1
and lipoxin A4 improve alveolarization and normalize
septal wall thickness in a neonatal murine model of
hyperoxia-induced lung injury. PLoS One. 9:e987732014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kair LR, Leonard DT and Anderson JM:
Bronchopulmonary dysplasia. Pediatr Rev. 33:255–264. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu L, Liu ZJ, Miao S, Zou LB, Cai L, Wu P,
Ye du Y, Wu Q and Li HH: Lipoxin A4 ameliorates cerebral
ischaemia/reperfusion injury through upregulation of nuclear factor
erythroid 2-related factor 2. Neurol Res. 35:968–975. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen XQ, Wu SH, Zhou Y and Tang YR:
Involvement of K+ channel-dependant pathways in lipoxin
A4-induced protective effects on hypoxia/reoxygenation
injury of cardiomyocytes. Prostaglandins Leukot Essent Fatty Acids.
88:391–397. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang F, Xie J, Wang W, Xie Y, Sun H, Jin
Y, Xu D, Chen B, Andersson R and Zhou M: Regional arterial infusion
with lipoxin A4 attenuates experimental severe acute pancreatitis.
PLoS One. 9:e108525. 2014.
|
|
25
|
Masini E, Vannacci A, Marzocca C,
Pierpaoli S, Giannini L, Fantappié O, Mazzanti R and Mannaioni PF:
Heme oxygenase-1 and the ischemia-reperfusion injury in the rat
heart. Exp Biol Med (Maywood). 228:546–549. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chok MK, Ferlicot S, Conti M, Almolki A,
Dürrbach A, Loric S, Benoît G, Droupy S and Eschwège P:
Renoprotective potency of heme oxygenase-1 induction in rat renal
ischemia-reperfusion. Inflamm Allergy Drug Targets. 8:252–259.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Paine A, Eiz-Vesper B, Blasczyk R and
Immenschuh S: Signaling to heme oxygenase-1and its
anti-inflammatory therapeutic potential. Biochem Pharmacol.
80:1895–1903. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ryter SW and Choi AM: Heme
oxygenase-1/carbon monoxide: From metabolism to molecular therapy.
Am J Respir Cell Mol Biol. 41:251–260. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rushworth SA, MacEwan DJ and O'Connell MA:
Lipopolysaccharide-induced expression of NAD (P)H: Quinone
oxidoreductase 1 and heme oxygenase-1 protects against excessive
inflammatory responses in human monocytes. J Immunol.
181:6730–6737. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
So Y, Lee SY, Han AR, Kim JB, Jeong HG and
Jin CH: Rosmarinic acid methyl ester inhibits LPS-induced NO
production via suppression of MyD88-dependent and -independent
pathways and induction of HO-1 in RAW 264.7 cells. Molecules.
21(pii): E10832016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu SH, Chen XQ, Lü J and Wang MJ: BML-111
attenuates renal ischemia/reperfusion injury via peroxisome
proliferator-activated receptor-α-regulated heme oxygenase-1.
Inflammation. 39:611–624. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu J, Hafner C, Schramel JP, Kaun C,
Krychtiuk KA, Wojta J, Boehme S, Ullrich R, Tretter EV, Markstaller
K and Klein KU: Cyclic and constant hyperoxia cause inflammation,
apoptosis and cell death in human umbilical vein endothelial cells.
Acta Anaesthesiol Scand. 60:492–501. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Deng H, Mason SN and Auten RL Jr: Lung
inflammation in hyperoxia can be prevented by antichemokine
treatment in newborn rats. Am J Respir Crit Care Med.
162:2316–2323. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Aslam M, Baveja R, Liang OD,
Fernandez-Gonzalez A, Lee C, Mitsialis SA and Kourembanas S: Bone
marrow stromal cells attenuate lung injury in a murine model of
neonatal chronic lung disease. Am J Respir Crit Care Med.
180:1122–1130. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bry K, Hogmalm A and Bäckström E:
Mechanisms of inflammatory lung injury in the neonate: Lessons from
a transgenic mouse model of bronchopulmonary dysplasia. Semin
Perinatol. 34:211–221. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ryan RM, Ahmed Q and Lakshminrusimha S:
Inflammatory mediators in the immunobiology of bronchopulmonary
dysplasia. Clin Rev Allergy Immunol. 34:174–190. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ishihara K and Hirano T: IL-6 in
autoimmune disease and chronic inflammatory proliferative disease.
Cytokine Growth Factor Rev. 13:357–368. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Donegan JJ, Girotti M, Weinberg MS and
Morilak DA: A novel role for brain interleukin-6: Facilitation of
cognitive flexibility in rat orbitofrontal cortex. J Neurosci.
34:953–962. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hao Y, Jing H, Bi Q, Zhang J, Qin L and
Yang P: Intra-amygdala microinfusion of IL-6 impairs the auditory
fear conditioning of rats via JAK/STAT activation. Behav Brain Res.
275:88–95. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wong LM, Myers SJ, Tsou CL, Gosling J,
Arai H and Charo IF: Organization and differential expression of
the human monocyte chemoattractant protein 1 receptor gene.
Evidence for the role of the carboxyl-terminal tail in receptor
trafficking. J Biol Chem. 272:1038–1045. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cho ML, Yoon BY, Ju JH, Jung YO, Jhun JY,
Park MK, Park SH, Cho CS and Kim HY: Expression of CCR2A, an
isoform of MCP-1 receptor, is increased by MCP-1, CD40 ligand and
TGF-beta in fibroblast like synoviocytes of patients with RA. Exp
Mol Med. 39:499–507. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Han J and Sun P: The pathways to tumor
suppression via route p38. Trends Biochem Sci. 32:364–371. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hui L, Bakiri L, Stepniak E and Wagner EF:
p38alpha: A suppressor of cell proliferation and tumorigenesis.
Cell Cycle. 6:2429–2433. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mishra S, Mishra JP and Kumar A:
Activation of JNK-dependent pathway is required for HIV viral
protein R-induced apoptosis in human monocytic cells: Involvement
of antiapoptotic BCL2 and c-IAP1 genes. J Biol Chem. 282:4288–4300.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhao Y, Wang CL, Li RM, Hui TQ, Su YY,
Yuan Q, Zhou XD and Ye L: Wnt5a promotes inflammatory responses via
nuclear factor κB (NF-κB) and mitogen-activated protein kinase
(MAPK) pathways in human dental pulp cells. J Biol Chem.
292:43582017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu SH, Lu C, Dong L, Zhou GP, He ZG and
Chen ZQ: Lipoxin A4 inhibits TNF-α-induced production of
interleukins and proliferation of rat mesangial cells. Kidney Int.
68:35–46. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Goh J, Baird AW, O'Keane C, Watson RW,
Cottell D, Bernasconi G, Petasis NA, Godson C, Brady HR and
MacMathuna P: Lipoxin A4 and aspirin-triggered
15-epi-lipoxin A4 antagonize TNF-alpha-stimulated
neutrophil-enterocyte interactions in vitro and attenuate
TNF-alpha-induced chemokine release and colonocyte apoptosis in
human intestinal mucosa ex vivo. J Immunol. 167:2772–2780. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Arditi M, Zhou J, Torres M, Durden DL,
Stins M and Kim KS: Lipopolysaccharide stimulates the tyrosine
phosphorylation of mitogen-activated protein kinases p44, p42, and
p41 in vascular endothelial cells in a soluble CD14-dependent
manner. Role of protein tyrosine phosphorylation in
lipopolysaccharide-induced stimulation of endothelial cells. J
Immunol. 155:3994–4003. 1995.PubMed/NCBI
|
|
49
|
Matsuda T, Omori K, Vuong T, Pascual M,
Valiente L, Ferreri K, Todorov I, Kuroda Y, Smith CV, Kandeel F and
Mullen Y: Inhibition of p38 pathway suppresses human islet
production of pro-inflammatory cytokines and improves islet graft
function. Am J Transplant. 5:484–493. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Alphonse RS, Vadivel A, Coltan L, Eaton F,
Barr AJ, Dyck JR and Thébaud B: Activation of Akt protects alveoli
from neonatal oxygen-induced lung injury. Am J Respir Cell Mol
Biol. 44:146–154. 2011. View Article : Google Scholar : PubMed/NCBI
|
